Loading...



Technical Sentiment Analysis for Franklin Genomic Advancements ETF (HELX). As of 2026-03-04, Franklin Genomic Advancements ETF (HELX) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 6 indicators are flashing buy, while 7 are indicating sell.
Momentum Indicators: RSI, MACD & Overbought/Oversold Status. Currently, the Relative Strength Index (RSI) for HELX stands at 32.85, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.63, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at - and the Commodity Channel Index (CCI) at -171.96 further confirm a -1.54 outlook for the ETF.
Support, Resistance & Moving Averages. From a structural perspective, HELX is trading above its 60-day moving average of $36.24 and above its 200-day long-term moving average of $32.19. Key price levels to watch include the immediate resistance at $35.19 and strong support at $33.61. A break above $35.19 could signal a bull continuation, while falling below $33.61 may test the next Fibonacci floor at $32.84.
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 32.03 | 32.84 | 33.61 | 34.42 | 35.19 | 36 | 36.77 |
| Fibonacci | 32.84 | 33.45 | 33.82 | 34.42 | 35.03 | 35.4 | 36 |
2026-03-04
| Name | Value |
|---|---|
| Relative Strength Index (RSI) | 32.85 |
| Stochastic Oscillator | - |
| Stochastic RSI | 14.84 |
| Commodity Channel Index (CCI) | -171.96 |
| Awesome Oscillator | -1.55 |
| Momentum | -1.54 |
| MACD | -0.63 |
2026-03-04
| Period | Simple | Signal |
|---|---|---|
| 5-Day | 34.14 | Sell |
| 10-Day | 34.37 | Sell |
| 20-Day | 34.65 | Sell |
| 60-Day | 36.24 | Sell |
| 200-Day | 32.19 | Buy |
| 250-Day | 31.12 | Buy |